Clinical Trial Update: Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo [Phase 2]

View source ↗

Summary

Phase 2 study of AS012 in non-segmental vitiligo completed; efficacy and safety results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• AS012

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Non-segmental Vitiligo | Phase 2 | Status: COMPLETED | Results posted: 2025-03-10